AMERITHROID
Live / Applied — Statement of use — processing complete, to examiner (as of 21 Jul 2026)
What this means for you
Not registered yet, but its 02 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98113807
- Mark type
- Stylized text
- Filed
- 02 Aug 2023
- Published for opposition
- 06 Feb 2024
- Attorney of record
- Stephen A. Seach, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hypothyroidism
Owner
- Oliva Therapeutics, LLC, Ridgewood, NJ, US
- Oliva Therapeutics, LLC, Ridgewood, NJ, US
Prosecution history
- 21 Jul 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 15 May 2026 — USE AMENDMENT FILED
- 15 May 2026 — TEAS STATEMENT OF USE RECEIVED
- 17 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Mar 2026 — SOU EXTENSION 4 GRANTED
- 16 Mar 2026 — SOU EXTENSION 4 FILED
- 16 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2025 — SOU EXTENSION 3 GRANTED
- 30 Sept 2025 — SOU EXTENSION 3 FILED
- 30 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Apr 2025 — SOU EXTENSION 2 GRANTED
- 02 Apr 2025 — SOU EXTENSION 2 FILED
- 02 Apr 2025 — SOU TEAS EXTENSION RECEIVED